Physician

David M Brey, MD

According to 2025 Medicare claims, David Brey, MD (NPI: 1114962362) practices rheumatology in the Owensboro, KY market, with the plurality of this provider's patient population coming from Daviess, KY. This provider's primary affiliated billing organization is LAKE CUMBERLAND RHEUMATOLOGY, PLLC (NPI: 1619117058; TIN: 264240766) and primary practice location at 42303-1705. Brey is affiliated with the Caravan Health ACO 50 LLC (ACO ID: A5160), participating under the MSSP model.

Brey's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 147 traditional Medicare patients, billed 28,234 HCPCS/CPT codes, and received $338,620 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 356 prescription claims across 102 beneficiaries totaling $104,621 in drug costs, led by Hydroxychloroquine Sulfate (Hydroxychloroquine Sulfate). Open Payments data shows 21 records totaling $351. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $84,972 to $338,620. In contrast, Part D prescription costs have fallen sharply in recent years, from $1,451,064 to $104,621. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	586	1,506	$84,972
2016	582	1,467	$73,450
2017	657	1,710	$78,507
2018	756	1,864	$92,336
2019	691	1,805	$82,027
2020	622	1,532	$68,770
2021	567	1,405	$78,356
2022	281	628	$17,155
2023	N/R	N/R	N/R
2024	147	28,234	$338,620

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	518	3,998	$1,451,064
2016	528	4,466	$1,724,010
2017	637	4,661	$2,051,034
2018	746	4,133	$2,011,676
2019	643	3,536	$2,062,318
2020	645	3,851	$3,042,534
2021	719	4,685	$3,704,172
2022	676	3,632	$3,621,036
2023	37	63	$61,038
2024	102	356	$104,621

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	41	41	$116
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	33	52	$96
96413	Administration of chemotherapy into vein, 1 hour or less	22	37	$84
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	40	77	$45
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	27	4,750	$33

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	93	4,130	$1,142
Prednisone	Prednisone	64	2,265	$253
Duloxetine Hcl	Duloxetine Hcl	25	1,110	$252
Methotrexate	Methotrexate Sodium	25	1,043	$206
Gabapentin	Gabapentin	20	600	$153

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	21	$351	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David M. Brey, MD?

Tedicare shows public-source Medicare data for David M. Brey, MD (NPI 1114962362), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David M. Brey, MD have ACO affiliation data?

David M. Brey, MD is shown with ACO affiliation data for Caravan Health ACO 50 LLC (MSSP, ACO ID A5160).

What billing organization is linked to David M. Brey, MD?

David M. Brey, MD is linked to LAKE CUMBERLAND RHEUMATOLOGY, PLLC (billing NPI 1619117058) in the available physician profile data.

Does David M. Brey, MD have Open Payments data?

David M. Brey, MD has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.